IGC Pharma (IGC) Amortizatization of Intangibles (2020 - 2022)
IGC Pharma (IGC) reported Amortizatization of Intangibles of $26000.0 for Q3 2022, little changed year-over-year from $26000.0 in Q3 2021, and down 7.14% quarter-over-quarter from $28000.0 in Q2 2022.
IGC Pharma (IGC) Amortizatization of Intangibles (2020 - 2022) Analysis & Trends
IGC Pharma (IGC) has 3 years of Amortizatization of Intangibles data on file, last reported at $26000.0 in Q3 2022.
- Amortizatization of Intangibles for Q3 2022 came in at $26000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2022 was $116000.0 (up 107.14% YoY), and the FY2022 annual result was $115000.0, up 422.73% from the prior year.
- Amortizatization of Intangibles retreated to $26000.0 in Q3 2022 per IGC's latest filing, from $28000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $35000.0 in Q1 2022 and troughed at -$2000.0 in Q3 2020.
- A 3-year average of $19100.0 and a median of $26000.0 in 2021 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2021 and 2022: Amortizatization of Intangibles jumped 2600.0% in 2021, then changed 0.0% in 2022.
- A 3-year view of Amortizatization of Intangibles shows it stood at $1000.0 in 2020, then jumped by 2600.0% to $27000.0 in 2021, then dropped by 3.7% to $26000.0 in 2022.
- Business Quant data shows IGC's Amortizatization of Intangibles at $26000.0 in Q3 2022, $28000.0 in Q2 2022, and $35000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | IGC Pharma | 27.49 Mn | 27.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 26,000.00 |
| Sep 30, 2022 | 26,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | 35,000.00 |
| Mar 31, 2022 | 35,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 27,000.00 |
| Jun 30, 2021 | 27,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Jun 30, 2020 | 21,000.00 |
| Jun 30, 2020 | 21,000.00 |